Stock Rating Upgrade
In the last week the Value Trend Rating for Capricor Therapeutics Inc (NASDAQ: CAPR) improved from D to C reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
Capricor Therapeutics Inc (NASDAQ: CAPR) stock closed at $6.30 on 5/20/24 after an increase of 1.6%. This advance was accompanied by normal trading volume. The stock has been exceptionally strong relative to the market over the last nine months and has risen 18.9% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, CAPR is expected to continue to be Value Creation neutral.
Capricor Therapeutics has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Capricor Therapeutics has a very low Appreciation Score of 3 but a very high Power Rating of 86, with the Low Neutral Value Trend Rating the result.
Be the first to comment